臺灣癌症用藥事前審查實作指引
0.2.0 - ci-build

This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v0.2.0: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Observation: 基因資訊

狀態：final

類型：基因資訊 (NHI-補充資訊類別值集#companionDiagnostics)

code：Genetic variant assessment (LOINC#69548-6)

病人：Patient/pat-min

基因檢測日期：2024-05-07

基因檢測機構：Organization 臺北市立聯合醫院

基因檢測分析結果：Absent (LOINC Answer List LL1971-2 #LA9634-2)

基因臨床判讀結果：Positive (ObservationInterpretationCodes #POS)

基因檢測檢體類型：Specimen/spe-min

基因報告：DocumentReference/doc-gene-min